Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance Document: Q9: Quality Risk Management
Q9: Quality Risk Management. This guidance has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. The ICH Steering Committee has endorsed the final draft and recommended its adoption by the regulatory bodies of the European Union, Japan and USA.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-11-01
Data overview
- Formats
- HTML
- File languages
- English, French
Official sources and licences
Resources
- Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance Document: Q9: Quality Risk Management (English, HTML) HTML
- Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance Document: Q9: Quality Risk Management (French, HTML) HTML